New York, November 01, 2018: The Global Meningococcal Vaccines Market is expected to exceed more than US$ 4.4 billion by 2022 and will grow at a CAGR of more than 12% in the given forecast period.
Meningococcal meningitis, otherwise called cerebrospinal meningitis, is brought on by Neisseria meningitides (Nm) microscopic organisms. It is an infectious disease of the layers encompassing the cerebrum and spinal line and transmits from individual to individual through respiratory beads. It can bring about serious cerebrum harm and is deadly in half of the cases if not treated at the right time; and can leave diligent neurological deformities in upwards of 10-15% of survivors.
The scope of the report includes a detailed study of global and regional markets on Global Meningococcal Vaccines Market with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Pfizer, JN-International Medical Corporation, Novartis International AG, GlaxoSmithKline plc, Sanofi S.A. Inc., Serum Institute of India Ltd., Nuron Biotech. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Global Meningococcal Vaccines Market has been segmented as below:
The Global Meningococcal Vaccines Market is Segmented on the lines of Type Analysis and Regional Analysis. By Type Analysis this market is segmented on the basis of Polysaccharide Vaccines, by Brand its covers Menomune, Mencevax, NmVac4, Others, Quadri Meningo & Bi Meningo. Conjugate Vaccines, by Brand its covers Menactra, Menveo, NeisVac-C, Nimenrix, Meningitec, Menjugate, MenAfriVac & NmVac4-DT. Combination Vaccines, by Brand its covers MenHibrix & Menitorix. Men B Vaccines, by Brand its covers Bexsero & Trumenba.
By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.
This report provides:
1) An overview of the global market for Global Meningococcal Vaccines Market and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Global Meningococcal Vaccines Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
Request Sample Report from here: https://www.marketresearchengine.com/reportdetails/meningococcal-vaccines-market-report
Table of Contents
1.1 KEY TAKE AWAYS
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.5 RESEARCH METHODOLOGY
1.5.1 MARKET SIZE
1.5.2 MARKET SHARE
1.5.3 KEY DATA POINTS FROM SECONDARY SOURCES
1.5.4 KEY DATA POINTS FROM PRIMARY SOURCES
2 Research Methodology
3 Global Meningococcal Vaccines Market Overview
4 Global Meningococcal Vaccines Market, by Type
5 Global Meningococcal Vaccines Market, by Geography
6 Competitive Landscape
8 Company Profiles
8.1 Baxter International, Inc.
8.2 Biomed Pvt., Ltd.
8.3 GlaxoSmithKline plc
8.4 JN-International Medical Corporation
8.5 Nuron Biotech, Inc.
8.6 Pfizer, Inc.
8.7 Sanofi SA
8.8 Serum Institute of India, Ltd.
Other Related Market Research Reports:
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States